Mandate

Vinge advises Doconomy in connection with its EUR 34 million Series B round

June 05, 2024

Vinge has advised Doconomy AB, a fintech start-up that provides banks with resources to promote financial health and climate action, in connection with its EUR 34 million Series B funding round. The round was led by UBS Next, the VC and innovation arm of UBS, and existing investor CommerzVentures, which acted as co-lead. Other shareholders who participated in the round include Motive Ventures, PostFinance and Tenity.

The funding will support Doconomy's product offering and expansion in North America, fostering broader adoption and engagement of the tools Doconomy provides.

Vinge's team consisted primarily of Jonas Johansson, Maria Dahlin Kolvik, Måns Håkansson and Ida Appelgren.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025